MRSN MERSANA THERAPEUTICS INC Investor Conferences 8-K Filing 2023 - Press Release Mersana Therapeutics issued a press release regarding Silicon Valley Bank and announced a clinical hold on its phase 1 clinical trial of XMT-2056.Get access to all SEC 8-K filings of the MERSANA THERAPEUTICS INC